Status:

COMPLETED

How DHEA Supplements Affect Coagulation in Women Using Birth Control Pills

Lead Sponsor:

Oregon Health and Science University

Conditions:

Contraceptive Usage

Coagulation

Eligibility:

FEMALE

18-44 years

Phase:

PHASE4

Brief Summary

A randomized study is to learn more about how a supplement called DHEA (dehydroepiandrosterone) affects clotting factors in women taking combined oral contraceptive pills. Current research suggests th...

Detailed Description

While the pro-thrombotic effects of estrogens are well established in women using combined oral contraception (COC), controversy exists over whether the various synthetic progestogens (progestins) use...

Eligibility Criteria

Inclusion

  • Women of reproductive age (18-44 years) in generally good health and with body mass index (BMI) between 18 and 35kg/m2
  • Premenopausal, with uterus and at least one ovary intact
  • Current users (at least 3 months) of combined oral contraception consisting of 0.02 mg (milligram) ethinyl estradiol and 3 mg drospirenone
  • Willing to continue use of current combined oral contraception for the next three menstrual cycles
  • Have a prescription for combined oral contraception consisting of ethinyl estradiol and drospirenone for the next four cycles
  • Not currently using androgen supplementation
  • Willing and able to sign the informed consent
  • Willing to comply with the study requirements and visit schedule
  • No desire to conceive during study participation, approximately 3 months

Exclusion

  • Currently enrolled in another clinical trial
  • Contraindications to androgen supplementation; history of polycystic ovarian syndrome (PCOS)
  • Known or suspected pregnancy, pregnancy within 3 months before study enrollment, or desire to conceive during study participation
  • Currently breastfeeding
  • Known or suspected alcoholism or drug abuse

Key Trial Info

Start Date :

January 16 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 11 2019

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT03418363

Start Date

January 16 2018

End Date

December 11 2019

Last Update

January 23 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Oregon Health & Science University

Portland, Oregon, United States, 97239